ABSTRACT Using comprehensive analysis of heart rate (HRV) and blood pressure (BPV) short‐term variability we estimated the time course of changes of autonomic nervous system remodeling in two stages of… Click to show full abstract
ABSTRACT Using comprehensive analysis of heart rate (HRV) and blood pressure (BPV) short‐term variability we estimated the time course of changes of autonomic nervous system remodeling in two stages of doxorubicin‐induced cardiomyopathy (DCM). We also investigated the level of gene expression of cardiac &bgr;‐1 (&bgr;‐1AR) and &bgr;‐2 (&bgr;‐2AR) adrenoceptors. Experiments were performed in adult male Wistar rats equipped with indwelling catheters for BP recording and blood withdrawal. A 15 mg/kg total cumulative dose of doxorubicin was injected i.p. to rats to induce DCM or saline for control (n=18). Rats were assessed for general toxicity, cardiovascular hemodynamic and echocardiography before treatment (n=6), 35 days (DOX35; n=6) and 70 days (DOX70; n=6) post‐treatment. HRV was evaluated by spectral analysis, Poincaré plots, sample and approximate entropy. Expression of &bgr;‐1AR and &bgr;‐2AR mRNA was evaluated by RT‐qPCR. Doxorubicin‐treated rats exhibited poor general condition and lower survival than saline‐treated rats. In DOX35 rats, there were no echocardiography signs of decompensation, no increase in serum cardiac troponins, but there was an increase of HRV and decrease of HR complexity. In these rats typical microscopic signs of cardiotoxicity were seen along with over‐expression of &bgr;‐1AR mRNA. 70 days post‐treatment echocardiography revealed signs of decompensation and serum cardiac troponin T was increased. At this stage BPV decreased. In conclusion, HRV increase matches transient over‐expression of cardiac &bgr;‐1AR mRNA in compensate stage of DCM while decompensate stage of DCM is characterized by a decrease of BPV and no changes in &bgr;‐1AR and &bgr;‐2AR gene expression. HIGHLIGHTSHRV, BPV, &bgr;‐1AR and &bgr;‐2AR gene expression at two stages of DCM were investigated.Compensate DCM show HRV increase, loss of HR complexity and &bgr;‐1AR over‐expression.Decompensate DCM exhibit a decrease in BPV and no changes in &bgr;‐AR gene expression.Thus, &bgr;‐1AR receptor blockade should be considered in early DCM.
               
Click one of the above tabs to view related content.